You have 9 free searches left this month | for more free features.

Impairement

Showing 26 - 50 of 66

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Mepolizumab and Physical Activity in Severe Asthma

Not yet recruiting
  • Asthma
  • Asthma; Eosinophilic
    • (no location specified)
    May 31, 2022

    Adults With Severe Eosinophilic Asthma on Benralizumab.

    Active, not recruiting
    • Severe Eosinophilic Asthma
    • Survey Administration
    • Calgary, Alberta, Canada
    • +19 more
    Dec 1, 2022

    Metabolic and Infectious Diseases in La Réunion

    Recruiting
    • Infectious Disease
    • +3 more
    • Blood, DNA, feces, urine, hair and skin microbiota collection
    • La Réunion, Saint-Pierre, France
      Centre Hospitalier Universitaire de La Réunion
    Jun 29, 2022

    Chronic Renal Insufficiency Trial in Sofia (STIRIPENTOL oral administration)

    Not yet recruiting
    • Chronic Renal Insufficiency
    • STIRIPENTOL oral administration
    • Sofia, Bulgaria
      Mc Comac Medical
    Feb 9, 2023

    Epithelial Ovarian Cancer, Acute Kidney Injury Due to Circulatory Failure Trial (Sodium Sulfate, Hydration, Cisplatin)

    Not yet recruiting
    • Epithelial Ovarian Cancer
    • Acute Kidney Injury Due to Circulatory Failure
    • Sodium Sulfate
    • +2 more
    • (no location specified)
    May 17, 2023

    Effort Test asTherapeutic Monitoring Tool in Acute

    Completed
    • Rhabdomyolysis Linked to a Hereditary Disease of Metabolism
    • Effort test
    • Functional tests on fibroblasts
    • Paris, France
      Hôpital Necker-Enfants Malades
    Oct 10, 2022

    Peripheral Arterial Disease Trial in Lausanne (High-intensity interval training group (HIIT), Low-to-moderate intensity training

    Not yet recruiting
    • Peripheral Arterial Disease
    • High-intensity interval training group (HIIT)
    • Low-to-moderate intensity training group (LowMod group)
    • Lausanne, Vaud, Switzerland
      CHUV
    Nov 10, 2022

    Bone, Peripheral Artery Disease Trial in Orleans (Assessment of BMD by DXA and HRpQCT)

    Recruiting
    • Bone
    • Peripheral Artery Disease
    • Assessment of BMD by DXA and HRpQCT
    • Orleans, France
      CHR d'ORLEANS
    Sep 2, 2021

    Renal Impairment Trial in Orlando, Bucuresti (BAF312)

    Completed
    • Renal Impairment
    • Orlando, Florida
    • +1 more
    Dec 6, 2020

    Language of Sleepiness

    Recruiting
    • Sleep
    • +2 more
      • La Jolla, California
      • +1 more
      Nov 3, 2020

      Quality of Life, Non Invasive Ventilation Trial (Quality of life and sleep questionnaire)

      Not yet recruiting
      • Quality of Life
      • Non Invasive Ventilation
      • Quality of life and sleep questionnaire
      • (no location specified)
      May 5, 2022

      Dry Eye Disease Trial in Newport Beach, Indianapolis, Andover (OC-01 (varenicline) nasal spray, Placebo (vehicle) nasal spray)

      Completed
      • Dry Eye Disease
      • OC-01 (varenicline) nasal spray
      • Placebo (vehicle) nasal spray
      • Newport Beach, California
      • +2 more
      Oct 21, 2021

      Metabolic Syndrome, Diabete Type 2, Kidney Insufficiency Trial in Cairo (Vildagliptin, Captopril Tablets, MetFORMIN 500 Mg Oral

      Unknown status
      • Metabolic Syndrome
      • +2 more
      • Cairo, Egypt
        National Diabetes & Endocrinology Institute
      Jul 21, 2020

      Pain, Opioids Trial in Bialystok (biochemical measurements)

      Completed
      • Pain
      • Opioids
      • biochemical measurements
      • Bialystok, Poland
        Urszula Kosciuczuk
      Feb 17, 2021

      Dry Eye Disease (DED) Trial in United States (OC-01 (varenicline) nasal spray, Placebo (vehicle) nasal spray)

      Completed
      • Dry Eye Disease (DED)
      • OC-01 (varenicline) nasal spray
      • Placebo (vehicle) nasal spray
      • Phoenix, Arizona
      • +21 more
      Oct 22, 2021

      Malignant Pleural Mesothelioma Trial in Worldwide (MORAb-009 (Amatuximab), Pemetrexed, Cisplatin)

      Completed
      • Malignant Pleural Mesothelioma
      • MORAb-009 (Amatuximab)
      • +2 more
      • Birmingham, Alabama
      • +27 more
      Aug 24, 2022

      One Year Follow-up After Rescuscited Cardiac Arrest

      Completed
      • Cardiac Arrest
        • Montpellier, France
          Uhmontpellier
        Nov 10, 2021

        Assessment of Movement Skills in Autism Spectrum Disorder

        Unknown status
        • Movement Disorders
        • Movement Assessment Battery for children
        • (no location specified)
        Feb 24, 2019

        Atopic Dermatitis Trial in Rotterdam (DermaCura® Chitosan based antimicrobial therapeutic clothing, Binamed® silver based

        Unknown status
        • Atopic Dermatitis
        • DermaCura® Chitosan based antimicrobial therapeutic clothing
        • +2 more
        • Rotterdam, Zuid-Holland, Netherlands
          Erasmus University Medical Center
        Jul 21, 2020

        After Primary or Revision Shoulder Arthroplasty WithPatient-

        Enrolling by invitation
        • Arthroplasty, Replacement, Shoulder
        • +2 more
        • reversed glenoid prothesis
        • Herentals, Belgium
        • +4 more
        Aug 12, 2019

        Dedifferentiated Liposarcoma Trial in Worldwide (Selinexor, Placebo)

        Completed
        • Dedifferentiated Liposarcoma
        • Los Angeles, California
        • +70 more
        Jan 5, 2023

        Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (Dexamethasone, Lenalidomide, Thalidomide)

        Completed
        • Recurrent Plasma Cell Myeloma
        • Refractory Plasma Cell Myeloma
        • Houston, Texas
          M D Anderson Cancer Center
        Oct 12, 2020

        Plaque Psoriasis Trial in Germany (Fumaric Acid Esters, Methotrexate, Ixekizumab)

        Completed
        • Plaque Psoriasis
        • Fumaric Acid Esters
        • +2 more
        • Augsburg, Germany
        • +20 more
        Sep 25, 2019

        Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in

        Active, not recruiting
        • Metastatic Melanoma
        • +22 more
        • Ipilimumab
        • +3 more
        • Birmingham, Alabama
        • +24 more
        Jan 19, 2023

        Mental and Behavioral Disorders, Withdrawal State Trial in London (Nicotine)

        Completed
        • Mental and Behavioral Disorders
        • Withdrawal State
        • London, United Kingdom
          Tobacco Dependence Research Unit
        Mar 26, 2019